VEGFA and neoplasm: Multiple mechanisms can contribute to tumor regression in vivo which include decrease in vascular endothelial growth factor (VEGF) [42, 43], signal transduction inhibition, G0/G1 cell cycle arrest [37], apoptosis and antibody-dependent cell-mediated cytotoxicity (ADCC) [37].